(Q37228658)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18661429%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

review article

1 reference

title

Insulin resistance and metabolic syndrome in chronic liver diseases: old entities with new implications (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18661429%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

1 reference

1 reference

chronic liver disease

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18661429%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

George Papatheodoridis

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18661429%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

author name string

Spilios Manolakopoulos

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18661429%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Athanasios J Archimandritis

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18661429%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

publication date

1 January 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18661429%20AND%20SRC:MED&resulttype=core&format=json

Scandinavian Journal of Gastroenterology

11 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18661429%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

volume

44

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18661429%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18661429%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

page(s)

6-14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18661429%20AND%20SRC:MED&resulttype=core&format=json

Insulin resistance: a metabolic pathway to chronic liver disease

11 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1080%2F00365520802273058

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802273058

A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802273058

21 January 2018

The metabolic syndrome

1 reference

https://api.crossref.org/works/10.1080%2F00365520802273058

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802273058

High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: a potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802273058

Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802273058

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802273058

Non-alcoholic steatohepatitis and metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802273058

High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802273058

Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802273058

Review article: hepatic steatosis and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802273058

Nonalcoholic fatty liver disease: from steatosis to cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802273058

High prevalence of elevated liver enzymes in blood donors: associations with male gender and central adiposity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802273058

Nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802273058

Steatohepatitis: a tale of two "hits"?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802273058

The natural history of nonalcoholic fatty liver disease: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802273058

Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802273058

Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802273058

Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802273058

Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802273058

Increased prevalence of fatty liver in arterial hypertensive patients with normal liver enzymes: role of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802273058

Metabolic syndrome is associated with severe fibrosis in chronic viral hepatitis and non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802273058

Metabolic syndrome is associated with greater histologic severity, higher carbohydrate, and lower fat diet in patients with NAFLD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802273058

High prevalence of hepatitis C infection in Afro-Caribbean patients with type 2 diabetes and abnormal liver function tests.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802273058

Diabetes mellitus in chronic hepatitis B and C: prevalence and potential association with the extent of liver fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802273058

Association of diabetes mellitus and chronic hepatitis C virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802273058

Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression [corrected].

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802273058

Hepatitis C Virus Down-Regulates Insulin Receptor Substrates 1 and 2 through Up-Regulation of Suppressor of Cytokine Signaling 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802273058

Impaired IRS-1/PI3-kinase signaling in patients with HCV: a mechanism for increased prevalence of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802273058

Peroxisome proliferator-activated receptor-alpha and -gamma mRNA levels are reduced in chronic hepatitis C with steatosis and genotype 3 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802273058

Non-response to antiviral therapy is associated with obesity and increased hepatic expression of suppressor of cytokine signalling 3 (SOCS-3) in patients with chronic hepatitis C, viral genotype 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802273058

Defective Hepatic Response to Interferon and Activation of Suppressor of Cytokine Signaling 3 in Chronic Hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802273058

Suppressor of cytokine signaling 3 (SOCS3) expression and hepatitis C virus-related chronic hepatitis: Insulin resistance and response to antiviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802273058

Insulin resistance and HCV: will new knowledge modify clinical management?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802273058

Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802273058

Impact of steatosis on progression of fibrosis in patients with mild hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802273058

Steatosis in chronic hepatitis C: relative contributions of obesity, diabetes mellitus, and alcohol

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802273058

Effect of treatment with peginterferon or interferon alfa-2b and ribavirin on steatosis in patients infected with hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802273058

Liver steatosis in chronic hepatitis C: a morphological sign suggesting infection with HCV genotype 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802273058

Hepatic steatosis in genotype 4 chronic hepatitis C is mainly because of metabolic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802273058

Hepatic steatosis in chronic hepatitis B develops due to host metabolic factors: a comparative approach with genotype 1 chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802273058

Combination of oxidative stress and steatosis is a risk factor for fibrosis in alcohol-drinking patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802273058

An in vitro model of hepatitis C virus genotype 3a-associated triglycerides accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802273058

Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral-related steatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802273058

Hepatitis C virus induced hypobetalipoproteinemia: a possible mechanism for steatosis in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802273058

Hepatic steatosis and insulin resistance: does etiology make a difference?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802273058

Analysis of histopathological manifestations of chronic hepatitis C virus infection with respect to virus genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802273058

Steatosis affects chronic hepatitis C progression in a genotype specific way

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802273058

Steatosis accelerates fibrosis development over time in hepatitis C virus genotype 3 infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802273058

Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802273058

Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802273058

Insulin resistance is associated with liver fibrosis in non-diabetic chronic hepatitis C patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802273058

Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802273058

Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802273058

Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802273058

Insulin resistance and response to therapy in patients infected with chronic hepatitis C virus genotypes 2 and 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802273058

The evolving role of leptin and adiponectin in chronic liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802273058

An assessment of serum leptin levels in patients with chronic viral hepatitis: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802273058

Adiponectin and its receptors in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802273058

Serum adiponectin correlates with viral characteristics but not histologic features in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802273058

Correlation of serum leptin levels with anthropometric and metabolic parameters and biochemical liver function in Chinese patients with chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802273058

Hypoadiponectinemia predicts the severity of hepatic fibrosis and pancreatic Beta-cell dysfunction in nondiabetic nonobese patients with nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802273058

Insulin resistance and liver injury in hepatitis C is not associated with virus-specific changes in adipocytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802273058

Genotype-specific mechanisms for hepatic steatosis in chronic hepatitis C infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802273058

Insulin resistance plays a significant role in liver fibrosis in chronic hepatitis C and in the response to antiviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802273058

Insulin resistance is associated with steatosis in nondiabetic patients with genotype 1 chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802273058

Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802273058

The impact of insulin resistance, serum adipocytokines and visceral obesity on steatosis and fibrosis in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802273058

Post-load insulin resistance is an independent predictor of hepatic fibrosis in virus C chronic hepatitis and in non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802273058

Race, insulin resistance and hepatic steatosis in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520802273058